Appendix E - National Coverage Determinations Manual / LEVOCARNITINE_FOR_USE_IN_THE_TREATMENT_OF_CARNITINE_DEFICIENCY_IN_ESRD_PATIENTS

Article Overview

This Appendix E article from the National Coverage Determinations Manual describes Medicare’s national coverage policy for intravenous levocarnitine in ESRD patients on dialysis. It explains the clinical documentation expected for coverage consideration, the general categories of qualifying symptoms, the timing and continuation expectations for treatment, and the circumstance under which other uses are not covered in the ESRD population. The article is relevant to dialysis providers, coders, billers, and compliance staff who need to understand policy-level coverage criteria for this therapy.